Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents

NCT00598715 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Sirolimus eluting stent
DEVICE: Paclitaxel-eluting stent

Sponsor

Deutsches Herzzentrum Muenchen